Thursday, December 23, 2021

Also As Expected -- Going Into Holiday Shut-Down: FDA Has Approved BOTH "At Home" COVID-19 Pills


It is hard to overstate how much this will change the number of deaths (by reducing the number of hospitalizations-needed -- for most severe symptoms).

This is very good news, regardless of which manufacturer one backs.

Here's that news -- from NBC News:

. . .The Food and Drug Administration on Thursday authorized Merck’s antiviral pill to treat Covid-19 for emergency use, adding another tool in the nation's arsenal to combat the virus.

The FDA's move comes a day after it authorized another antiviral drug, from Pfizer. Merck's treatment, known as molnupiravir and developed in partnership with Ridgeback Biotherapeutics, is cleared for use in adults with mild to moderate Covid who are at risk for severe disease, the agency said in a statement. Pfizer's pill was authorized for people as young as 12. . . .


Onward, now to the Scottsdale museums in the sunshine, here -- while we await the youngest, and partner. Smiling. . . .

नमस्ते

No comments: